Clinical Trial Update: A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001) [Phase 3]

View source ↗

Summary

Phase 3 long-term safety study of Org 50081 (Esmirtazapine) in elderly outpatients with chronic primary insomnia completed; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Elderly Sleep Disorders
• Insomnia
• Sleep Initiation and Maintenance Disorder

Drugs mentioned

• Org 50081

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Sleep Initiation and Maintenance Disorder; Elderly, Mental Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-07-07